Corbus Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Corporate Updates
12. August 2021 08:05 ET
|
Corbus Pharmaceuticals Holdings, Inc.
Company focused on gaining regulatory clarity for late-stage lenabasum program and advancing programs targeting the endocannabinoid system and integrins into the clinicAugmenting the pipeline through...
Green Hygienics Holdings Inc. (GRYN) Executes Agreement with Cinvestav, the Leading Mexican Academic Research Institution, to Advance Research Targeting Endocannabinoid System (ECS) Deficiencies
20. Mai 2021 08:30 ET
|
Green Hygienics Holdings Inc.
SAN DIEGO, May 20, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Green Hygienics Holdings Inc. (OTCQB: GRYN) ("Green Hygienics" or the "Company") is pleased to announce it has entered into a...
Green Hygienics Holdings Inc. (GRYN) Executes Agreement with Cinvestav, the Leading Mexican Academic Research Institution, to Advance Research Targeting Endocannabinoid System (ECS) Deficiencies
20. Mai 2021 08:30 ET
|
Green Hygienics Holdings Inc.
SAN DIEGO, May 20, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Green Hygienics Holdings Inc. (OTCQB: GRYN) ("Green Hygienics" or the "Company") is pleased to announce it has entered into a...
Green Hygienics Holdings Inc. (GRYN) Launches TruLife Biotech, LLC. to Advance the Study of Hemp-derived Cannabinoid Therapeutics
04. Mai 2021 09:00 ET
|
Green Hygienics Holdings Inc.
SAN DIEGO, May 04, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Green Hygienics Holdings Inc. (OTCQB: GRYN) ("Green Hygienics" or the "Company"), announces today that it will move forward with the...
Corbus Pharmaceuticals to Present at Two Upcoming Investor Conferences
09. März 2021 08:05 ET
|
Corbus Pharmaceuticals Holdings, Inc.
Norwood, MA, March 09, 2021 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a clinical-stage drug development company pioneering transformative...
Corbus Pharmaceuticals to Report Fourth Quarter and Year-End 2020 Results on March 15, 2021
08. März 2021 08:05 ET
|
Corbus Pharmaceuticals Holdings, Inc.
• Company to host conference call and webcast on Monday, March 15, 2021 at 8:30 a.m. ET Norwood, MA, March 08, 2021 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP)...
Corbus Pharmaceuticals Announces Presentations at the New York Academy of Sciences Webinar on Targeting the Endocannabinoid System to Treat Human Diseases
20. Januar 2021 08:05 ET
|
Corbus Pharmaceuticals Holdings, Inc.
Presentations about compounds in Corbus’ pipeline will highlight mechanistic studies of lenabasum, a CB2 agonist, and preclinical data from CB2 agonist oncology program and CB1 inverse agonist...
Corbus Pharmaceuticals to Present at the Jefferies Virtual London Healthcare Conference
12. November 2020 08:05 ET
|
Corbus Pharmaceuticals Holdings, Inc.
Fireside chat with live audio webcast on Thursday, November 19th at 12:35 PM EST Norwood, MA, Nov. 12, 2020 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the...
Corbus Pharmaceuticals to Report Third Quarter Results on November 10, 2020
03. November 2020 08:05 ET
|
Corbus Pharmaceuticals Holdings, Inc.
Company to host conference call and webcast on Tuesday, November 10 at 8:30 a.m. ET Norwood, MA, Nov. 03, 2020 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus”...
Corbus Pharmaceuticals to Report First Quarter Results on May 11, 2020
04. Mai 2020 08:05 ET
|
Corbus Pharmaceuticals Holdings, Inc.
- Management to host conference call and webcast on Monday, May 11 at 8:30 a.m. ET- NORWOOD, MA, May 04, 2020 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or...